Imipenem versus moxalactam in the treatment of serious infections.

Imipenem (formerly imipemide, N-formimidoyl thienamycin, or MK0787) was compared to moxalactam in a randomized therapeutic trial involving 39 evaluable patients with serious bacterial infections. Of those treated with imipenem, 89% were cured or improved versus 60% for moxalactam (P = 0.06). Althoug...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Eron, L J, Hixon, D L, Park, C H, Goldenberg, R I, Poretz, D M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185393/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6581755/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.6.841
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!